Cary Street Partners Investment Advisory LLC Royalty Pharma PLC Transaction History

Cary Street Partners Investment Advisory LLC

  • $2.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$29.6 - $36.56 $1,036 - $1,279
35 Added 13.21%
300 $9,000
Q1 2023

May 12, 2023
BUY
$32.77 - $39.4 $2,130 - $2,561
65 Added 32.5%
265 $9,000
Q4 2022

Feb 14, 2023
BUY
$39.17 - $44.04 $7,834 - $8,808
200 New
200 $7,000

Others Institutions Holding RPRX

# of Institutions
413
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email